CL
DGX icon

Choreo LLC’s Quest Diagnostics DGX Stock Holding History

Choreo LLC’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$443K Sell
2,261
-973
-30% -$189K 0.01% 1010
2025
Q4 		$568K Buy
3,234
+132
+4% +$24K 0.01% 865
2025
Q3 		$591K Buy
3,102
+987
+47% +$175K 0.01% 851
2025
Q2 		$380K Buy
2,115
+453
+27% +$78.7K 0.01% 1048
2025
Q1 		$281K Buy
1,662
+72
+5% +$11.8K ﹤0.01% 1126
2024
Q4 		$240K Buy
1,590
+285
+22% +$44.3K ﹤0.01% 1315
2024
Q3 		$201K Buy
+1,305
New +$195K ﹤0.01% 1470

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Choreo LLC's DGX Position: Q1 2026 in Review

Choreo LLC reduced its Quest Diagnostics (DGX) stake by 30% in Q1 2026, selling an estimated $189K and leaving 2,261 shares worth $443K. The position accounts for 0.01% of the portfolio, ranked #1010.

Choreo LLC first reported a position in DGX in Q3 2024 and has held it in 7 quarters since. The position peaked at $591K in Q3 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Choreo LLC held 2,261 shares of Quest Diagnostics worth $443K as of Q1 2026.
  • Choreo LLC sold 973 Quest Diagnostics shares in Q1 2026, an estimated $189K.
  • Quest Diagnostics made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #1010 holding.
  • Choreo LLC first reported a position in Quest Diagnostics in Q3 2024 and has held it in 7 quarters since.
  • Choreo LLC's Quest Diagnostics position peaked at $591K in Q3 2025.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.